Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene (original) (raw)
- Paper
- Published: 18 June 1998
- R Morishita2,
- I Kida2,
- T Yamakawa1,
- W Zhang1,
- M Aoki2,
- H Matsushita2,
- A Noda3,
- R Nagai4,
- Y Kaneda5,
- J Higaki2,
- T Ogihara2,
- Y Sawa1 &
- …
- H Matsuda1
Gene Therapy volume 5, pages 761–769 (1998) Cite this article
- 267 Accesses
- 41 Citations
- Metrics details
Abstract
The senescent cell-derived inhibitor (sdi)-1 (p21) protein has been identified as a downstream mediator of the tumor suppressor p53 in the cell cycle regulation. In this study, we focused on the function of sdi-1 gene in inhibiting vascular smooth muscle cell (VSMC) proliferation after vein grafting in a rabbit model. To test the hypothesis, we transfected human sdi-1 gene by an intra-operative approach. Accompanied by markedly increased sdi-1 protein, the significant increase in PCNA-stained VSMCs in vein grafts was inhibited by transfection of sdi-1 gene. Moreover, at 2 weeks after transfection, transfer of sdi-1 gene resulted in a significant inhibition in neointimal formation, compared with control vector. Of importance, immunohistological studies determining the expression pattern of myosin heavy isoforms, adult type specific SM2 and embryonic specific SMemb/NMHC-B, demonstrated expression of the adult phenotype of VSMCs in the neointima of sdi-1 gene-transfected vein grafts at 2 weeks after the operation, while the neointima was predominantly composed of embryonic phenotype of VSMCs in the control grafts. Overall, these results demonstrate that a single intraluminal incubation of human sdi-1 gene can result in a significant inhibition of neointimal formation after vein grafting, associated with phenotypic change of VSMCs from neonatal to adult type in a rabbit model. Inhibition of hyperplasia in a graft model by transfection of sdi-1 gene may be due to the change in VSMC phenotype from neonatal to adult, in addition to the inhibition of VSMC growth.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- First Department of Surgery, Osaka University Medical School, Japan
H Bai, T Yamakawa, W Zhang, Y Sawa & H Matsuda - Department of Geriatric Medicine, Osaka University Medical School, Japan
R Morishita, I Kida, M Aoki, H Matsushita, J Higaki & T Ogihara - Department of Radiation Biophysics, Kobe University, Japan
A Noda - Second Department of Internal Medicine, Gunma University Medical School, Japan
R Nagai - Institute for Cellular and Molecular Biology, Osaka University Medical School, Japan
Y Kaneda
Authors
- H Bai
- R Morishita
- I Kida
- T Yamakawa
- W Zhang
- M Aoki
- H Matsushita
- A Noda
- R Nagai
- Y Kaneda
- J Higaki
- T Ogihara
- Y Sawa
- H Matsuda
Rights and permissions
About this article
Cite this article
Bai, H., Morishita, R., Kida, I. et al. Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene.Gene Ther 5, 761–769 (1998). https://doi.org/10.1038/sj.gt.3300640
- Received: 05 September 1997
- Accepted: 18 December 1997
- Published: 18 June 1998
- Issue date: 01 June 1998
- DOI: https://doi.org/10.1038/sj.gt.3300640